Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Herpes Simplex Virus Vaccines
Studies from McMaster University, Center for Gene Therapeutics have provided new data on herpes simplex virus vaccines
December 31st, 2008
Current study results from the report, 'Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone,' have been published. "This study examined the effect of hormonal environment on intranasal and subcutaneous routes of immunization in a genital herpes infection model. Ovariectomized mice were treated with estradiol (E(2)), progesterone (P(4)) or placebo hormone pellets and immunized intranasally (i.n.) or subcutaneously (s.c.) with attenuated HSV-2," scientists writing in the journal Vaccine report. "Immunized mice were subsequently challenged, intravaginally, with...
Source: Vaccine Weekly (2008-12-31)
|
